# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-09T20:28:46.887233
**Route:** OpenRouter + LaTeX
**Tokens:** 23766 in / 1685 out
**Response SHA256:** 378b151a9a7773e1

---

I checked the draft for the specific classes of FATAL errors you asked me to screen for (data-design alignment, regression sanity, completeness, internal consistency). I found no fatal problems. Key checks I ran:

- Data-design alignment
  - Treatment timing vs data coverage: The analysis uses ACS 1-year PUMS for 2017–2019 and 2021–2024 (2020 excluded). Treatment cohorts include adoptions through 2024; control states include states adopting in 2025 (ID, IA). Max(treatment year) = 2024 and max(data year) = 2024, so treated states can appear as treated in the sample and the 2025 adopters are correctly coded as untreated in the sample. The July-1 half-year rule for mapping effective dates to survey years is explicitly documented.
  - Post-treatment observations: The event-time mapping table shows post periods for cohorts consistent with the stated survey years (e.g., 2021 cohort has post periods through 2024). The manuscript also notes that CS-DiD dynamic aggregation is limited to e ≤ 2 for reliable estimates and documents the 2021 cohort’s e = 3 being thin—this is internally consistent.
  - Treatment definition consistency: The paper documents that adopt_year is encoded in replication code, and the event-time mapping table matches the described cohort treatment coding. I found no explicit mismatch between the treatment-timing description in text and the timing_map table.

- Regression sanity
  - Reported coefficients and standard errors in the text are in plausible ranges for percentage-point outcomes (e.g., ATT = -0.50 pp, SE = 0.63 pp; post-PHE ATT = -2.18 pp, SE = 0.74 pp; DDD = +0.99 pp, SE = 1.55 pp). No impossibly large SEs or coefficients are reported in the main text. No negative SEs, NaN/Inf, or R² outside [0,1] are presented anywhere in the draft.
  - The manuscript repeatedly documents the number of clusters and uses cluster-robust SEs, wild cluster bootstrap, permutation inference and state-cluster bootstrap for CS-DiD, which addresses few-cluster concerns. The SEs and CIs reported look reasonable for the outcomes involved.

- Completeness
  - I searched the main text and appendices for placeholder tokens such as NA, TBD, TODO, PLACEHOLDER, XXX and found none.
  - The draft reports sample sizes (per-year and totals) in the Data Appendix table. The paper states that regression tables report number of clusters and 95% CIs; event-study figures and many robustness tables are referenced. The LaTeX source uses \input for tables and figures (standard), and the manuscript text consistently references these tables/figures. There are no explicit broken references to missing figures/tables in the main text.
  - Methods described (CS-DiD, DDD, permutation, WCB, HonestDiD) are all matched with results and robustness sections reporting those procedures.

- Internal consistency
  - Numbers quoted in the abstract and main text match the numbers described in the relevant result sections (e.g., full-sample CS-DiD ATT = -0.50 pp; post-PHE = -2.18 pp; DDD = +0.99 pp).
  - The sample period and treatment timing language is consistent across sections (2017–2019 pre, 2023–2024 post-PHE, 2024-only robustness).
  - Specification descriptions match the labels of the reported estimates in the results text (e.g., DDD using state×postpartum and year×postpartum fixed effects).

Given the checks above, I found no fatal errors of the types you instructed me to catch.

ADVISOR VERDICT: PASS